Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biosimilar Firms Say Irish Price Deal Hinders Uptake, As Govt Plans New Policy Measures

Executive Summary

The Irish health ministry is planning measures to boost the prescribing of biosimilar medicines, but companies marketing biosimilars say that the pricing agreement signed last year by the originator industry and the government has served to hinder uptake of their products.

Advertisement

Related Content

Irish Health Minister Speaks About EMA Relocation, Drug Pricing, and Boosting Biosimilars
Irish Health Minister Speaks About EMA Relocation, Drug Pricing, and Boosting Biosimilars
New Irish Generics Body Wants “Fundamental” Reform Of Medicines Procurement
New Irish Generics Body Wants “Fundamental” Reform Of Medicines Procurement
Scrip Asks… Is The Biosimilar Cost-Saving Theory Sustainable?
Scrip Asks… Is The Biosimilar Cost-Saving Theory Sustainable?
Industry Bodies Warn Against Switching Among Biosimilars
Biosimilars Boost In Europe: 2017 Kicks Off With Three Approvals And Backing From ESMO
Ireland Prepares New Biosimilar Policy To Improve Access, Boost Industry
Irish Drug Prices Face Annual Cuts Under New Four-Year Deal

Topics

Advertisement
UsernamePublicRestriction

Register

PS120023

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel